Dr Stephen Bourke
Dr Simon Doe
Dr Carlos Echevarria
| Corrigendum to “Optimising outcomes for adults with Cystic Fibrosis taking CFTR modulators by individualising care: Personalised data linkage to understand treatment optimisation (PLUTO), a novel clinical framework” [Respirat. Med. 239 (2025)](S0954611125000575)(10.1016/j.rmed.2025.107995) | 2025 |
|
Dr Carlos Echevarria
Professor Anthony De Soyza
| 1-year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort study | 2024 |
|
Dr John Steer
Dr Carlos Echevarria
Professor Stephen Bourke
Dr Nicholas Lane
| Global mortality and readmission rates following COPD exacerbation-related hospitalisation: a meta-analysis of 65 945 individual patients | 2024 |
|
Dr Carlos Echevarria
Dr John Steer
Dr Arun Prasad
Professor Stephen Bourke
| Admission blood eosinophil count, inpatient death and death at 1 year in exacerbating patients with COPD | 2023 |
|
Dr Carlos Echevarria
Ruth Penfold
Dr Katie Haighton
Dr Beth Nichol
| Correction: The effect of COVID rehabilitation for ongoing symptoms Post HOSPitalisation with COVID-19 (PHOSP-R): protocol for a randomised parallel group controlled trial on behalf of the PHOSP consortium (Trials, (2023), 24, 1, (61), 10.1186/s13063-023-07093-7) | 2023 |
|
Dr Lisa Alcock
Dr Philip Brown
Dr Carlos Echevarria
Dr Kirsty Scott
Professor Lynn Rochester
et al. | Laboratory and free-living gait performance in adults with COPD and healthy controls | 2023 |
|
Dr Carlos Echevarria
Ruth Penfold
| The effect of COVID rehabilitation for ongoing symptoms Post HOSPitalisation with COVID-19 (PHOSP-R): protocol for a randomised parallel group controlled trial on behalf of the PHOSP consortium | 2023 |
|
Dr Stephen Bourke
Dr Simon Doe
Dr Carlos Echevarria
Dr Meenakshi Choudhary
Kevin McEleny
et al. | Current status of fertility and family formation in men with cystic fibrosis | 2021 |
|
Dr Carlos Echevarria
Dr Colin Muirhead
Dr John Steer
Professor John Simpson
Dr Grant Gibson
et al. | Hot decaf: a rct comparing home treatment and inpatient care in copd exacerbations selected by low risk decaf score | 2016 |
|
Lorelle Dismore
Dr Carlos Echevarria
Professor John Simpson
Dr Grant Gibson
Professor Stephen Bourke
et al. | Positive drivers and potential barriers to implementation of hospital at home selected by low risk decaf score | 2016 |
|
Dr Carlos Echevarria
Dr John Steer
Dr Chris Stenton
Dr Ian Steen
Professor John Simpson
et al. | Validation of the DECAF score to predict hospital mortality in acute exacerbations of COPD | 2016 |
|
Dr Carlos Echevarria
Dr John Steer
Dr Chris Stenton
Dr Ian Steen
Professor John Simpson
et al. | The PEARL score predicts 90 day readmission or death following hospitalisation for an exacerbation of COPD | 2015 |
|
Dr Carlos Echevarria
Professor Stephen Bourke
| Case-based discussion from North Tyneside General Hospital: somatostatin analogues in yellow nail syndrome associated with recurrent pleural effusions | 2014 |
|
Dr Carlos Echevarria
Professor Stephen Bourke
| Profound bradycardia associated with NIV removal | 2012 |
|
